Torben Altmann
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 1
- Oncology 8
- CAR-T cell therapy research 7
- Chemokine receptors and signaling 1
- Co-authors
- Thomas Köhnke (8 shared papers)Wolfgang Hiddemann (7 shared papers)Marion S. Subklewe (6 shared papers)Christina Krupka (7 shared papers)Peter Kufer (4 shared papers)Karsten Spiekermann (4 shared papers)Gerhard Zugmaier (3 shared papers)P.A. Bäuerle (1 shared paper)
- Journals
- Blood (5 papers)Leukemia (1 paper)Haematologica (1 paper)Oncotarget (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- GermanyNorwayUnited States
In The Last Decade
Torben Altmann
10 papers receiving 348 citations
Peers
Comparison fields: 5 of 35
- Oncology 235
- Hematology 99
- Immunology 171
- Radiology, Nuclear Medicine and Imaging 84
- Physiology 9
Countries citing papers authored by Torben Altmann
This map shows the geographic impact of Torben Altmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torben Altmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torben Altmann more than expected).
Fields of papers citing papers by Torben Altmann
This network shows the impact of papers produced by Torben Altmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torben Altmann. The network helps show where Torben Altmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Torben Altmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 217 | |
| 2 | 2016 | 55 | |
| 3 | 2017 | 33 | |
| 4 | 2020 | 33 | |
| 5 | 2016 | 8 | |
| 6 | 2014 | 5 | |
| 7 | 2014 | 4 | |
| 8 | 2014 | 3 | |
| 9 | 2014 | 2 | |
| 10 | 2016 | 1 |
About Torben Altmann
Torben Altmann is a scholar working on Immunology, Oncology, Hematology, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 10 papers that have together received 361 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (5 papers), Acute Myeloid Leukemia Research (3 papers), Immunotherapy and Immune Responses (3 papers), RNA Interference and Gene Delivery (3 papers), Acute Lymphoblastic Leukemia research (2 papers), T-cell and B-cell Immunology (1 paper) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Oncology (235 citations), Hematology (99 citations), Immunology (171 citations), Radiology, Nuclear Medicine and Imaging (84 citations) and Physiology (9 citations). Torben Altmann has collaborated with scholars based in Germany, Norway and United States. Frequent co-authors include Thomas Köhnke, Wolfgang Hiddemann, Marion S. Subklewe, Christina Krupka, Peter Kufer, Karsten Spiekermann, Gerhard Zugmaier, P.A. Bäuerle, Binje Vick and Irmela Jeremias. Their work appears in journals such as Blood, Leukemia, Haematologica, Oncotarget and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.